My treatment approach to rheumatoid arthritis

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification criteria for rheumatoid arthritis, better definitions of treatment outcome and remission, and the introduction of biologic response-modifying drugs designed to inhibit the inflammatory process have greatly altered the approach to managing this disease. More aggressive management of rheumatoid arthritis early after diagnosis and throughout the course of the disease has resulted in improvement in patient functioning and quality of life, reduction in comorbid conditions, and enhanced survival.

Original languageEnglish (US)
Pages (from-to)659-673
Number of pages15
JournalMayo Clinic Proceedings
Volume87
Issue number7
DOIs
StatePublished - 2012

Fingerprint

Rheumatoid Arthritis
Early Diagnosis
Therapeutics
Quality of Life
Survival
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

My treatment approach to rheumatoid arthritis. / Davis, John Manley III; Matteson, Eric Lawrence.

In: Mayo Clinic Proceedings, Vol. 87, No. 7, 2012, p. 659-673.

Research output: Contribution to journalArticle

@article{1171b1ab26bf4861892ad319f8e87420,
title = "My treatment approach to rheumatoid arthritis",
abstract = "The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification criteria for rheumatoid arthritis, better definitions of treatment outcome and remission, and the introduction of biologic response-modifying drugs designed to inhibit the inflammatory process have greatly altered the approach to managing this disease. More aggressive management of rheumatoid arthritis early after diagnosis and throughout the course of the disease has resulted in improvement in patient functioning and quality of life, reduction in comorbid conditions, and enhanced survival.",
author = "Davis, {John Manley III} and Matteson, {Eric Lawrence}",
year = "2012",
doi = "10.1016/j.mayocp.2012.03.011",
language = "English (US)",
volume = "87",
pages = "659--673",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "7",

}

TY - JOUR

T1 - My treatment approach to rheumatoid arthritis

AU - Davis, John Manley III

AU - Matteson, Eric Lawrence

PY - 2012

Y1 - 2012

N2 - The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification criteria for rheumatoid arthritis, better definitions of treatment outcome and remission, and the introduction of biologic response-modifying drugs designed to inhibit the inflammatory process have greatly altered the approach to managing this disease. More aggressive management of rheumatoid arthritis early after diagnosis and throughout the course of the disease has resulted in improvement in patient functioning and quality of life, reduction in comorbid conditions, and enhanced survival.

AB - The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification criteria for rheumatoid arthritis, better definitions of treatment outcome and remission, and the introduction of biologic response-modifying drugs designed to inhibit the inflammatory process have greatly altered the approach to managing this disease. More aggressive management of rheumatoid arthritis early after diagnosis and throughout the course of the disease has resulted in improvement in patient functioning and quality of life, reduction in comorbid conditions, and enhanced survival.

UR - http://www.scopus.com/inward/record.url?scp=84863467614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863467614&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2012.03.011

DO - 10.1016/j.mayocp.2012.03.011

M3 - Article

C2 - 22766086

AN - SCOPUS:84863467614

VL - 87

SP - 659

EP - 673

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 7

ER -